• Home
• About us
• Contact

• News
• People
• Products
• Deals
• Organisations

• » Follow us on twitter!
• » Get Free Newsletter!

Advertisement

Organisation › Details

United States (govt)

	City	n. a.
		Address record changed: 2011-05-15
Basic data	Employees	n. a.
		Record changed: 2020-03-15

Advertisement

More documents for United States (govt)

• [1] Valneva S.E.. (9/8/20). "Press Release: Valneva Initiates Phase 3 Clinical Study for its Chikungunya Vaccine Candidate VLA1553". Saint-Herblain....
• [2] Intravacc B.V.. (9/8/20). "Press Release: Intravacc Receives US NIH/NIAID Contract to Develop Enterovirus D68 Vaccine". Bilthoven....
• [3] MorphoSys AG. (8/1/20). "Press Release: FDA Approves Monjuvi (tafasitamab-cxix) in Combination with Lenalidomide for the Treatment of Adult Patients with Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL)". Planegg & Wilmington, DE....
• [4] BioNTech SE. (7/22/20). "Press Release: Pfizer and BioNTech Announce an Agreement with U. S. Government for up to 600 Million Doses of mRNA-based Vaccine Candidate Against SARS-CoV-2". New York, NY & Mainz....
• [5] Reapplix A/S. (7/14/20). "Press Release: Reapplix Receives New Reimbursement Coding and Completes USD 22.6m Equity Financing to Drive US Commercialization"....
• [6] MorphoSys AG. (7/14/20). "Press Release: MorphoSys' Licensee Janssen Announces Approval of Tremfya (Guselkumab) by U.S. FDA for Treatment of Adults with Active Psoriatic Arthritis". Planegg....
• [7] Inflazome Ltd.. (7/14/20). "Press Release: FDA Grants Orphan Drug Designation for Inflazome’s Inzomelid for the Treatment of Cryopyrin-Associated Periodic Syndromes (CAPS)". Dublin, Cambridge & Brisbane....
• [8] Freeline Therapeutics Ltd.. (5/4/20). "Press Release: Freeline Receives Orphan Drug Designation from the FDA for FLT190 for the Treatment of Fabry Disease". London....
• [9] Avectas Ltd.. (4/8/20). "Press Release: Avectas Announces Issuance of U.S. Patent for Cell Engineering Technology by the U.S. Patent and Trademark Office". Dublin....
• [10] Roche. (4/7/20). "Press Release: Roche Provides Regulatory Update on Risdiplam for the Treatment of Spinal Muscular Atrophy (SMA)". Basel....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2020. Made in Germany.